Copyright
©The Author(s) 2020.
World J Clin Cases. Apr 6, 2020; 8(7): 1326-1336
Published online Apr 6, 2020. doi: 10.12998/wjcc.v8.i7.1326
Published online Apr 6, 2020. doi: 10.12998/wjcc.v8.i7.1326
Figure 1 Brain metastases in the left cerebellar hemisphere (contrast-enhanced oblique axial T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
Figure 2 Brain metastases in the left cerebellar hemisphere (contrast-enhanced oblique sagittal T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
Figure 3 Brain metastases in the left temporal lobe (contrast-enhanced oblique coronal fat-suppression T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
Figure 4 Brain metastases in the left basal ganglia (contrast-enhanced oblique coronal fat-suppression T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
Figure 5 Brain metastases in the right cerebellar hemisphere (contrast-enhanced oblique coronal fat-suppression T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
Figure 6 Brain metastases in the cerebellar hemisphere (contrast-enhanced oblique sagittal T1 weighted images).
A: Pretreatment; B: After 3 mo of treatment; C: After 6 mo of treatment; D: After 12 mo of treatment.
- Citation: Guo JH, Wang YY, Zhang JW, Liu PM, Hao YJ, Duan HR. Clinical effects of apatinib mesylate for treatment of multiple brain micrometastases: Two case reports. World J Clin Cases 2020; 8(7): 1326-1336
- URL: https://www.wjgnet.com/2307-8960/full/v8/i7/1326.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i7.1326